There has been an increase in the number of claims that cannabidiol (CBD) has the potential to treat viral infections. Even though studies suggest that CBD can be used successfully in treating viral diseases, there is still no clear clinical evidence.
At the time of writing, “Cannabidiol for Viral Diseases: Hype or Hope?” is the latest scientific review on the ability of cannabidiol (CBD) to treat viral infections.
There has been an increase in the number of claims that cannabidiol (CBD) has the potential to treat people with certain viral infections. Yet, to this date, the scientific community has focused very little on verifying these claims.
In this latest study, scientists reviewed all evidence available on PubMed and claims on the Internet, to evaluate the “current state of knowledge” on the use of CBD to treat viral infections or as an antiviral agent.
The PubMed search retrieved only three articles. One is supporting the use of CBD to treat Hepatitis C, the second to treat Kaposi sarcoma, and the last one describing the capacity of CBD to decrease neuroinflammation in a virus-induced animal model of Multiple Sclerosis.
As for the Internet search, it located 25 (mostly commercial) websites listing more indications for CBD, which were not supported by appropriate scientific references.
Even though the articles mentioned above, identified through PubMed, suggest that CBD can be used successfully in treating viral diseases, there is still a lack of clear clinical evidence.
Similarly, CBD use based on personal observations retrieved from the Internet also lacks support by scientific evidence. Nonetheless, these anecdotal cases may be pointing towards conditions linked with viral infections that will also be worth checking in well-designed clinical trials, hopefully soon.
CARINA PINTO KOZMUS
ŽELJKO PERDIJA M.D.
Go to the Ardoa Market to buy the broadest spectrum CBD oil legally available in Europe.